Ryan Specialty (NYSE:RYAN - Get Free Report) had its target price cut by investment analysts at UBS Group from $59.00 to $51.00 in a report issued on Monday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price objective suggests a potential upside of 72.15% from the company's previous close.
Several other research firms have also issued reports on RYAN. Cantor Fitzgerald reduced their target price on Ryan Specialty from $45.00 to $40.00 and set a "neutral" rating for the company in a report on Thursday, April 9th. BMO Capital Markets lowered Ryan Specialty from an "outperform" rating to a "market perform" rating and reduced their target price for the company from $66.00 to $43.00 in a report on Wednesday, February 25th. Morgan Stanley dropped their price objective on Ryan Specialty from $55.00 to $50.00 and set an "overweight" rating on the stock in a research note on Monday, April 6th. Royal Bank Of Canada initiated coverage on Ryan Specialty in a research note on Tuesday, March 17th. They issued an "outperform" rating and a $45.00 price objective on the stock. Finally, Barclays decreased their target price on Ryan Specialty from $41.00 to $39.00 and set an "overweight" rating for the company in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of "Hold" and an average target price of $48.12.
View Our Latest Research Report on Ryan Specialty
Ryan Specialty Stock Down 3.9%
Shares of Ryan Specialty stock traded down $1.21 on Monday, hitting $29.63. The company had a trading volume of 3,110,772 shares, compared to its average volume of 2,147,277. The stock has a market capitalization of $7.83 billion, a price-to-earnings ratio of 38.47, a P/E/G ratio of 0.86 and a beta of 0.68. Ryan Specialty has a 1 year low of $29.50 and a 1 year high of $72.50. The stock has a 50 day moving average of $36.08 and a 200-day moving average of $46.33. The company has a debt-to-equity ratio of 2.90, a quick ratio of 0.98 and a current ratio of 1.02.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $795.23 million during the quarter, compared to the consensus estimate of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The company's quarterly revenue was up 15.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.39 earnings per share. As a group, sell-side analysts forecast that Ryan Specialty will post 2.18 earnings per share for the current year.
Insider Transactions at Ryan Specialty
In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction on Monday, February 23rd. The shares were acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares of the company's stock, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 52.03% of the stock is owned by insiders.
Hedge Funds Weigh In On Ryan Specialty
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State of Michigan Retirement System lifted its holdings in shares of Ryan Specialty by 2.2% during the 1st quarter. State of Michigan Retirement System now owns 27,400 shares of the company's stock worth $924,000 after acquiring an additional 600 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Ryan Specialty by 0.9% during the 1st quarter. Principal Financial Group Inc. now owns 4,411,837 shares of the company's stock worth $148,856,000 after acquiring an additional 37,339 shares during the last quarter. J. Safra Sarasin Holding AG bought a new stake in shares of Ryan Specialty during the 1st quarter worth $303,000. Fifth Third Bancorp lifted its holdings in shares of Ryan Specialty by 4,844.4% during the 1st quarter. Fifth Third Bancorp now owns 32,089 shares of the company's stock worth $1,083,000 after acquiring an additional 31,440 shares during the last quarter. Finally, Torray Investment Partners LLC raised its position in Ryan Specialty by 12.7% in the 1st quarter. Torray Investment Partners LLC now owns 68,046 shares of the company's stock worth $2,296,000 after purchasing an additional 7,662 shares during the period. 84.82% of the stock is currently owned by hedge funds and other institutional investors.
About Ryan Specialty
(
Get Free Report)
Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.
Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.